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THYROID
In reviewing the matter of endocrine advances during the past year or two, it
seems evident that the discovery and subsequent clinical use of Thiourecil is the
outstanding achievement. Since the original use of the drug by Astwood and his
associates in 1943 (1) much interest has centered on the question of what ultimate
value Thiouracil would have in the treatment of thyroroxicosis. Considerable
skepticism was expressed in the early stages of its use, (2) and conflicting reports
of its efficacy have been published during the last few months. Two and a half
years have now elapsed since the first use of the drug, and in January of this
year a comprehensive report was published by Robert H. Williams (3) giving
the effect of prolonged treatment and the toxic reactions observed in 247 patients
treated in the Harvard Medical School Clinics. Briefly, it appears to be estab-
lished that Thiouracil in doses varying from .6 gm. to .3 gm. daily will produce
remissions in patients with thyrotoxicosis; that thyroidectomy is accompanied by
less thyrotoxic reactions when Thiouracil is used, even though the gland is rendered
more vascular and friable than with the use of iodides; that combined administra-
tion of Thiouracil and iodides is desirable; and that toxic reactions may be expected
in 14 per cent of cases. Toxic reactions are found to be more common with pro-
longed use of the drug and when unnecessarily large doses are used. Most impor-
tant in the long list of toxic manifestations are leucopenia, agranulocytosis, fever,
and various anaphylactic reactions. It has been suggested that the body capacity
to bind protein is responsible for the anaphylactic reactions as well for the actual
therapeutic effect of the drug (4). Work is. rapidly going ahead in the perfection
of new anti-thyroid drugs for which hope of non-toxicity is held—and only time
will tell to what extent these drugs may supersede surgery in the treatment of
thyrotoxicosis.
PANCREAS
Efforts have been centered on improvement of diabetic control by producing
insulin preparations which will answer the 24-hour requirement. Protamine-zinc
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insulin was thought to be the answer to this, but only in mild cases requiring
less than 40 units daily has it been possible to rely on protamine to prevent hyper-
glycemia during the day, without producing hypoglycemia during the night.
A mixture of regular or crystalline insulin and protamine-zinc insulin in the
ratio of 1 :3 has been quite satisfactory, but is impractical from the standpoint
of the ease of administration.
Globin-zinc and histone-zinc preparations have been tried with disappointing
results.
In recent months, however, experiments have been made using a bi-phasic
insulin containing twenty-five per cent of the protamine in quickly absorbable
form, and seventy-five per cent in the present slowly absorbable precipitated form.
It is uncertain as yet whether or not this form will prove to be stable for marketable
use (7), (8).
MALE HYPOGONADISM
The male climacteric and sterility in the male have received a great deal of
attention during these past months. Carl G. Heller has contributed immensely
to the understanding of male hypogonadism by his comprehensive classification
of the various forms of testicular failure (9). His is one of several excellent reviews
of the problem published in the last two years. There is increasing interest in
the use of testicular biopsies as an aid in therapeutic evaluation of problems of
hypogonadism. Patients having complete hyalinization of seminiferous tubules
with partial Leydig-cell failure may be expected to respond favorably to treatment
with androgenic substitution therapy, whereas such patients would be totally
unresponsive to chorionic or pituitary gonadotropins from the standpoint of
subjective clinical relief of symptoms. It is to be understood that spermatogenesis
cannot be attained when complete hyalinization has occurred.
In patients demonstrating only an early sclerotic change in the seminiferous
tubules, with partial Leydig-cell failure, there is reason to hope that spermatogenesis
may be stimulated by the use of chorionic gonadotropins. The duration and
expense of both androgenic and gonadotropic therapy are of sufficient importance
to justify the wider use of testicular biopsies as an aid in therapeutic prognosis.
Since mumps orchitis is of such significance as a cause of sterility and of early
climacteric changes, interesting work is being done regarding its prevention.
Gamma globulin from mumps convalescent serum is proving effective in some
cases (10).
ADRENAL
Of practical importance from a diagnostic standpoint are the favorable reports
concerning the reliability of the Kepler test in Addison's disease (11). Further
studies have been made to determine the cause of faulty diuresis and the electrolyte
changes which are the basis for the test (12), in the hope that the diagnostic measures
may be further improved.
It is highly desirable to be able to discard a test such as the original Wilder test
involving salt deprivation which was attended by dangerous reactions.
STEROIDS
The literature in recent months has been laden with reports of the painstaking
efforts to isolate and differentiate the various androgenic steroids excreted in the
urine (13), (14). It is thought that increasing simplification of methods of extrac-
tion and increasing knowledge of the source of the various fractions will prove to be
extremely valuable in the diagnosis of adrenal and gonadal pathology. Abnor-
malities in which dependence for diagnosis is placed on the 17-ketosteroids, include
adrenal deficiency in male and females, hirsutism, virilism, amenorrhea, and
obesity in females, precocious puberty in males and females, adrenal cortical
No. 4 ENDOCRINOLOGY 187
tumor, gonadal tumors, and cancer in areas not associated with an endocrine
gland.
Pregnandiol excretion in the urine during prolonged amenorrhea is being urged
as a rapid, simple test for pregnancy (15). This method of testing was advocated
as early as 1931, but has not come into wide use due to difficulties encountered in
laboratory techniques. It is not yet certain whether or not the method is suffi-
ciently accurate to justify its use.
PITUITARY
Continued efforts are being made to isolate and purify the various anterior,
pituitary hormones, but outstanding progress has not yet been achieved.
FEMALE HYPOGONADISM
Menstrual disorders, and sterility are still the outstanding problems in this
field. In the last two years, there has been a better understanding of the impor-
tance of cyclic therapy in secondary amenorrhea and cases of sustained follicle
hyperplasia. The uses of testosterone and progesterone are better understood—
and there is a gradual and fortunate trend away from the indiscriminate use of
estrogens.
Improved pituitary gonadotropins will eventually fill a great need for physio-
logical ovarin stimulation.
Vaginal smears, stained by specific dyes, are now being widely used as a means
of differentiating the various degrees of epithelial cell growth in response to estrogen
hormone elaboration. This procedure has provided a practical and simple diagnosis
test which may be used in an office.
BIBLIOGRAPHY
1. Astwood, E. B. Thiouracil treatment in hyperthyroidism. Jr. Clin. Endocrinol., 4:
229-248, 1944.
2. Loskin, S., and Levine, R. Recent advances in physiology of the thyroid and their clinical
application. Arch. Int. Med., 74: 375, 1944.
3. Williams, Robt. H. Thiouracil treatment of thyrotoxicosis I and II. Jr. Clin. Endocrinol.,
6:1-51, 1946.
4. McArthur, Janet W., Rawson, R. W., and Means, J. H. Idiosyncratic Febrile Reactions to
Thiouracil. Ann. of Int. Med., 23: 6: 915, Dec, 1945.
5. McCullagh, E. Perry. Present Status of Thiouracil. Cleve. Clin. Quart., 13: 56-66,
April, 1946.
6. Crile, George, Jr., and Dinsmore, R. S. Present Status of Surgical Treatment of Hyper-
thyroidism. Cleve. Clin. Quart., 13: 50-56, April, 1946.
7. MacBryde, C. M.f and Reiss, R. Modified Protamine-zinc insulin. Jr. Clin. Endocrinol.,
4: 469-479, Oct., 1944.
8. MacBryde, C. M. (Editorial) Improved forms of Insulin. Jr. Clin. Endocrinol., 5:189-191,
April, 1945.
9. Heller, Carl G., and Nelson, W. O. Hyalinization of Seminiferous Tubules associated with
normal or failing Leydig-cell function (3 articles). Jr. Clin. Endocrinol., 5: 1-33, Jan.,
1945.
10. Gellis, Sidney S., McGuinness, Aims C, and Peters, Michael. Study on prevention
mumps orchitis by gamma globulin. Am. Jr. Med. Sc, 210: 5-661, Nov.,1945.
11. Robinson, F. J., Power, M. H., and Kepler, E. J. Two new procedures to assist in recog-
nition and exclusion of Addison disease. Proc. Staff Meet., Mayo Clinic, 16: 577, 1941.
12. Reforzo-Membrives, Juan, Power, M. H., and Kepler, E. J. Studies on renal excretion of
water and electrolytes in cases of Addison's disease. Jr. Clin. Endocrinol., 5: 76-85,
Feb., 1945.
13. Salter, W. T., Cahen, R. L., and Sappington, T. S. Urinary 17-Ketosteroids. Jr. Clin.
Endocrinol., 6: 52-76, Jan., 1946.
14. Pincus, Gregory. Analysis of Human Urines for Steroid Substances. Jr. Clin. Endocrinol.,
5:291-3.0, Sept., 1945.
15. Guterman, Henry S. Further observations on the value of the pregnandiol test for
pregnancy. Jr. Clin. Endocrinol., 5: 407-411, Dec, 1945.
